The important stage at the conversion of DMD patients‘ lung functions

Z. Li, J. Huang, Y. Luo, L. Peng, X. Yao (Guangzhou, Guangdong, China)

Source: Annual Congress 2007 - Respiratory muscles and breathing techniques in obstructive and neuromuscular diseases
Session: Respiratory muscles and breathing techniques in obstructive and neuromuscular diseases
Session type: Thematic Poster Session
Number: 1161
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Z. Li, J. Huang, Y. Luo, L. Peng, X. Yao (Guangzhou, Guangdong, China). The important stage at the conversion of DMD patients‘ lung functions. Eur Respir J 2007; 30: Suppl. 51, 1161

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How to evaluate the lung functions of DMD patients and the trend of conversion
Source: Eur Respir J 2007; 30: Suppl. 51, 183s
Year: 2007

Interleukine-17A implicated in survival outcome of patients with late stage lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018

Features affecting stages of patients with lung cancer at diagnosis
Source: Eur Respir J 2005; 26: Suppl. 49, 536s
Year: 2005

Cyst-related primary lung malignancies: an important and relatively unknown imaging appearance of (early) lung cancer
Source: Eur Respir Rev, 27 (150) 180079; 10.1183/16000617.0079-2018
Year: 2018



Surgery for non small cell lung cancer (NSCLC) and functional limits: is there a possible beneficial role of preoperative pulmonary rehabilitation?
Source: Eur Respir J 2004; 24: Suppl. 48, 522s
Year: 2004

Quantification of telomerase activity is important in predicting prognosis of patients with non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 482s
Year: 2005

Reflex testing  is crucial for treatment decisions in advanced non small cell lung cancer (NSCLC)
Source: International Congress 2017 – Chinese Programme 2017
Year: 2017

The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006

The influence of secondary infectious process on non-small cell lung cancer (NSCLC) patients survival
Source: Eur Respir J 2007; 30: Suppl. 51, 280s
Year: 2007

First hospitalization in lung cancer patients – is timing important?
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021


Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007


Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011


Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status
Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders
Year: 2017

The role of tumor size in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006

Recognition of aberrant promoter methylation for early diagnosis of lung cancer patients
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020

A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010


Characteristics and prognostic relevance of p53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Which functional alteration is mainly the cause in determining dyspnoeain COPD patients?
Source: Eur Respir J 2004; 24: Suppl. 48, 288s
Year: 2004

Stage I lung cancer patients with or without symptoms – are the patients any different?
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


Loss of heterozygosity detected in plasma DNA of early stage lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 673s
Year: 2004